Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid versus slower prednisolone tapering in newly diagnosed untreated rheumatoid arthritis
2020-005096-12Phase 4Active
- Sponsor
- Karolinska University Hospital
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisolone in rheumatoid arthritis (RA) (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Clinical efficacy at month 12. Started Apr 2021; status: active.
02
Drugs
prednisolone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2020-005096-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005096-12.